Mark Massaro
Stock Analyst at BTIG
(4.17)
# 1,577
Out of 4,692 analysts
1041
Total ratings
40.6%
Success rate
7.1%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MXCT MaxCyte | Reiterated: Hold | n/a | $1.29 | - | 30 | Aug 24, 2026 | |
| MDXH MDxHealth | Reiterated: Buy | $4 → $2 | $0.7202 | +177.70% | 15 | Aug 21, 2026 | |
| TEM Tempus AI | Maintained: Buy | $70 → $80 | $63.05 | +26.88% | 12 | Aug 20, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $3.92 | - | 24 | Aug 18, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $2.5 | $0.9786 | +155.47% | 25 | Aug 17, 2026 | |
| FRNM Freenome | Initiated Coverage: Buy | $17 | $14.79 | +14.94% | 1 | Aug 17, 2026 | |
| CERS Cerus | Reiterated: Buy | $4 | $2.64 | +51.52% | 25 | Aug 14, 2026 | |
| TKNO Alpha Teknova | Upgraded: Buy | $8 | $7.18 | +11.42% | 13 | Aug 11, 2026 | |
| NTRA Natera | Reiterated: Buy | $290 → $320 | $321.96 | -0.61% | 80 | Aug 7, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $32 → $33 | $25.49 | +29.46% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $60 | $50.11 | +19.74% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 → $130 | $90.67 | +43.38% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $7.34 | +22.62% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $8.40 | +7.14% | 19 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $84.81 | +6.12% | 37 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $44 | $33.03 | +33.21% | 35 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $190 → $195 | $159.02 | +22.63% | 49 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $24.92 | +0.32% | 43 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.91 | - | 35 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $16 | $16.78 | -3.16% | 38 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $9 → $5 | $6.81 | -26.58% | 27 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $77.10 | +107.52% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $556.69 | +43.71% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.22 | n/a | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $2.66 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $75 | $14.43 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $3.59 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $2.67 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 → $310 | $213.63 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $173 → $170 | $332.66 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $112 → $113 | $240.30 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.2787 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $19.00 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $149 → $145 | $188.11 | n/a | 2 | May 7, 2015 |
MaxCyte
Aug 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.29
Upside: -
MDxHealth
Aug 21, 2026
Reiterated: Buy
Price Target: $4 → $2
Current: $0.7202
Upside: +177.70%
Tempus AI
Aug 20, 2026
Maintained: Buy
Price Target: $70 → $80
Current: $63.05
Upside: +26.88%
Insight Molecular Diagnostics
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.92
Upside: -
Lucid Diagnostics
Aug 17, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.9786
Upside: +155.47%
Freenome
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $14.79
Upside: +14.94%
Cerus
Aug 14, 2026
Reiterated: Buy
Price Target: $4
Current: $2.64
Upside: +51.52%
Alpha Teknova
Aug 11, 2026
Upgraded: Buy
Price Target: $8
Current: $7.18
Upside: +11.42%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $290 → $320
Current: $321.96
Upside: -0.61%
Caris Life Sciences
Aug 7, 2026
Reiterated: Buy
Price Target: $32 → $33
Current: $25.49
Upside: +29.46%
Aug 6, 2026
Reiterated: Buy
Price Target: $45 → $60
Current: $50.11
Upside: +19.74%
Aug 6, 2026
Reiterated: Buy
Price Target: $142 → $130
Current: $90.67
Upside: +43.38%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $7.34
Upside: +22.62%
Aug 5, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $8.40
Upside: +7.14%
Aug 4, 2026
Reiterated: Buy
Price Target: $90
Current: $84.81
Upside: +6.12%
Aug 3, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $33.03
Upside: +33.21%
Jul 31, 2026
Reiterated: Buy
Price Target: $190 → $195
Current: $159.02
Upside: +22.63%
Jul 30, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $24.92
Upside: +0.32%
Jul 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.91
Upside: -
Jul 20, 2026
Maintained: Buy
Price Target: $11 → $16
Current: $16.78
Upside: -3.16%
Mar 12, 2026
Rated: Sell
Price Target: $9 → $5
Current: $6.81
Upside: -26.58%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $77.10
Upside: +107.52%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $556.69
Upside: +43.71%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
May 20, 2024
Maintained: Buy
Price Target: $2
Current: $2.66
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 17, 2019
Maintained: Buy
Price Target: $70 → $75
Current: $14.43
Upside: n/a
Nov 10, 2019
Maintained: Hold
Price Target: $7 → $8
Current: $3.59
Upside: n/a
Nov 6, 2019
Maintained: Buy
Price Target: $35
Current: $2.67
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $300 → $310
Current: $213.63
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $173 → $170
Current: $332.66
Upside: n/a
Oct 22, 2019
Maintained: Buy
Price Target: $112 → $113
Current: $240.30
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.2787
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $19.00
Upside: n/a
May 7, 2015
Maintained: Hold
Price Target: $149 → $145
Current: $188.11
Upside: n/a